# Study of JANX014 in Subjects With Metastatic Castration-Resistant Prostate Cancer

> clinical trial · VERIFIED · 2026-08-10

Status: RECRUITING · Sponsor: Janux Therapeutics · Condition: Prostate Cancer

- Company: Janux Therapeutics
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT07545811

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.